BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, June 17, 2026
Home » Blogs » BioWorld MedTech Perspectives » TDS next step in innovation

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

Medical technology

TDS next step in innovation

Nov. 1, 2012
By Omar Ford
images

Last month, I had the opportunity to witness something extraordinary. No, not the first presidential debate between President Obama and Governor Romney ... that's a discussion for another time blog.

What I saw that was so intriguing occurred at the Georgia Life Sciences Summit held here in Atlanta. I got the chance to see three college students present a technology that could significantly change the quality of life for paralyzed patients.

What I'm speaking about is Lingcast's (a start-up firm based out of Atlanta) Tongue Driven System (TDS). The device utilizes an tongue-computer interface that uses magnetic sensors to wirelessly track the motion of the user’s tongue within the oral cavity and translate its motions into set of commands that can be used to perform a multitude of tasks, including driving a wheelchair, controlling a cursor on a computer, smart phone or tablet (an article discussing the device at length appeared in October 5, edition of Medical Device Daily).

But what was more impressive than this innovative technique, are the students who were working on this project. Led by, Jacob Greenberg,  a student at the Emory University Law School , Georgia;  Nikhil Kurien, MBA Candidate, Georgia Tech Scheller College of Business, Georgia, and Hangue Park, PhD, Candidate in Electrical and Computer Engineering, from Georgia Institute of Technology; gave a key presentation that clearly matched the level of innovation of the TDS.

If these students are able bring the energy of this presentation into Lingcast's discussions with FDA, then TDS will be available on the market in no time.

Here's a brief demonstration on how TDS works.

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 16, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 16, 2026
  • Red blood cells, DNA

    For clonal hematopoiesis, epigenetics can be in driver’s seat

    BioWorld Science
    Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
  • In the clinic for June 12, 2026

    BioWorld
    Clinical updates for biopharma and med tech, including data readouts and publications: Anixa, Beone, Bioinvent, Blossomhill, C4, Cellectis, Climb, Elixiron,...
  • Illustration of amyloid plaques in Alzheimer's disease

    Elixiron’s enrupatinib shows upbeat interim phase II AD results

    BioWorld
    Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing